中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2008年
5期
336-338
,共3页
李永利%马洪滨%郭静霞%史佳彬%徐军%刘爱霞%杨丽华%李伯安%毛远丽
李永利%馬洪濱%郭靜霞%史佳彬%徐軍%劉愛霞%楊麗華%李伯安%毛遠麗
리영리%마홍빈%곽정하%사가빈%서군%류애하%양려화%리백안%모원려
甲胎蛋白类%癌%肝细胞
甲胎蛋白類%癌%肝細胞
갑태단백류%암%간세포
Alpha-fetoproteins%Carcinoma%hepatocellular
目的 探讨甲胎蛋白异质体(AFP-L3)的检测在预警原发性肝癌中的作用.方法 对100例AFP升高肝病患者血清,应用甲胎异质体微量离心柱分离并洗脱获得AFP-L3,再同时检测原始血清中的AFP以及AFP-L3含量,计算AFP-L3在AFP中的比例,对AFP-L3异常升高者、正常者进行跟踪,结合6个月后临床诊断结果 ,分析AFP-L3升高在鉴别良性肝脏病变与预警肝癌中的作用.结果 肝癌、疑似肝癌患者与良性肝病患者中的AFP-L3阳性率差异有统计学意义(分别为81.80%、73.68%、11.80%,P<0.05).未确诊肝癌(疑似HCC、肝病)的患者中,AFP-L3阳性的21例中有12例在6个月内被诊断为HCC,而且有6例是通过B超、CT等影像学手段被早期确诊的单发性小肝癌.AFP-L3阴性的62例标本中,6个月内有3例发生肝癌,AFP-L3阳性发生肝癌的危险率增加了11.9倍.结论 AFP-L3与AFP值无相关性,可以作为一个独立肝细胞癌诊断因子.AFP-L3的测定对于AFP升高时良、恶性肝病的鉴别及肝癌的早期预警诊断具有重要意义.
目的 探討甲胎蛋白異質體(AFP-L3)的檢測在預警原髮性肝癌中的作用.方法 對100例AFP升高肝病患者血清,應用甲胎異質體微量離心柱分離併洗脫穫得AFP-L3,再同時檢測原始血清中的AFP以及AFP-L3含量,計算AFP-L3在AFP中的比例,對AFP-L3異常升高者、正常者進行跟蹤,結閤6箇月後臨床診斷結果 ,分析AFP-L3升高在鑒彆良性肝髒病變與預警肝癌中的作用.結果 肝癌、疑似肝癌患者與良性肝病患者中的AFP-L3暘性率差異有統計學意義(分彆為81.80%、73.68%、11.80%,P<0.05).未確診肝癌(疑似HCC、肝病)的患者中,AFP-L3暘性的21例中有12例在6箇月內被診斷為HCC,而且有6例是通過B超、CT等影像學手段被早期確診的單髮性小肝癌.AFP-L3陰性的62例標本中,6箇月內有3例髮生肝癌,AFP-L3暘性髮生肝癌的危險率增加瞭11.9倍.結論 AFP-L3與AFP值無相關性,可以作為一箇獨立肝細胞癌診斷因子.AFP-L3的測定對于AFP升高時良、噁性肝病的鑒彆及肝癌的早期預警診斷具有重要意義.
목적 탐토갑태단백이질체(AFP-L3)적검측재예경원발성간암중적작용.방법 대100례AFP승고간병환자혈청,응용갑태이질체미량리심주분리병세탈획득AFP-L3,재동시검측원시혈청중적AFP이급AFP-L3함량,계산AFP-L3재AFP중적비례,대AFP-L3이상승고자、정상자진행근종,결합6개월후림상진단결과 ,분석AFP-L3승고재감별량성간장병변여예경간암중적작용.결과 간암、의사간암환자여량성간병환자중적AFP-L3양성솔차이유통계학의의(분별위81.80%、73.68%、11.80%,P<0.05).미학진간암(의사HCC、간병)적환자중,AFP-L3양성적21례중유12례재6개월내피진단위HCC,이차유6례시통과B초、CT등영상학수단피조기학진적단발성소간암.AFP-L3음성적62례표본중,6개월내유3례발생간암,AFP-L3양성발생간암적위험솔증가료11.9배.결론 AFP-L3여AFP치무상관성,가이작위일개독립간세포암진단인자.AFP-L3적측정대우AFP승고시량、악성간병적감별급간암적조기예경진단구유중요의의.
Objective To explore the significance of Lens culinaris-reactive α-Fetoprotein (AFP-L3) detection in primary hepatocellular carcinoma. Methods AFP-L3 was isolated by using microspincolumn coupled with lens culinaris agglutinin (LCA), AFP and AFP-L3 were detected with chemiluminescent immunoassay, the propertion of AFP L3 levels were calculated, and the relationship between the elevated AFP-L3 (%) levels and benign and malignant liver disease was analyzed. Results There were significant differences in positive rate between the patients of HCC, suspected HCC and other liver disease (81.80%, 73.68%, 11.80%, respectively, P < 0.05). Among the undetermined HCC (suspected HCC, liver disease) patients, 12 out of 21 cases of AFP-13 positive were diagnosed to be HCC within 6 months, and 6 of them were diagnosed to be the single small HCC at the early stage through B-Ultrasonic Diagnosis or CT. Among 62 cases of AFP-L3 negative, 3 cases were diagnosed to be HCC within 6 months and the risk of occurrence of HCC for AFP-L3 positive increased 11.9 times. Conclusion AFP-L3 has no correlation with AFP value, and it can be used as an independent HCC diagnosis factor. The detection of AFP-L3 has a significant implication for the identification of benign or malignant liver disease and the early stage predictive diagnosis of HCC while AFP increases